IRCT20171030037093N41
Recruiting
Phase 2
Comparison of the effectiveness of intranasal budesonide, oral montelukast and their combination in patients with allergic rhinitis
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- Allergic rhinitis.
- Sponsor
- Esfahan University of Medical Sciences
- Enrollment
- 135
- Status
- Recruiting
- Last Updated
- 5 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Having allergic rhinitis
- •Age over 15 years
Exclusion Criteria
- •Nasal polyps
- •Severe nasal deviation
- •Nasal tumor or mass
- •Get any treatment for allergic rhinitis within a week before the visit
- •Existence of severe underlying disease
- •Having Churg\-Strauss
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Not Applicable
Comparative efficacy and safety of two intranasal Triamcinolone Acetonide formulations in persistent allergic rhinitisPersistent allergic rhinitisEUCTR2005-002742-19-GBeolab Limited24
Not yet recruiting
Phase 2
Effect of midazolam through nasal versus intravenous route in controlling seizures in children.Health Condition 1: G969- Disorder of central nervous system, unspecifiedCTRI/2024/01/061644Government medical college and hospital, Chandigarh
Not yet recruiting
Not Applicable
Comparison two drug dexmedetomidine and ketamine for sedation in pediatric population via intranasal atomisor in pediatric patient undergoing surgical procedureHealth Condition 1: O- Medical and SurgicalCTRI/2024/05/066640Maharani laxmi bai medical college jhansi
Completed
Not Applicable
Dexmedetomidine versus ketamine by administration as nasal spray for sedation in children undergoing spine surgeryCTRI/2022/04/042249Ankur Luthra64
Completed
Phase 2
Comparison of intranasal midazolam and ketamine in peripheral IV access in childrePain and distress associated with peripheral IV access in children in emergency department.IRCT20200728048242N1Iran University of Medical Sciences100